IGM Biosciences Inc. (IGMS)
1.70
-0.01 (-0.58%)
At close: Jan 15, 2025, 11:40 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 112.52M | 121.23M | 133.33M | 241.08M | 35.89M | 1.89M | 432.00K |
| Short-Term Investments | 225.16M | 305.93M | 96.21M | 125.19M | 188.74M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | 11.97M | 100.00K | 50.00K |
| Other Long-Term Assets | 1.81M | 2.00M | 1.04M | 548.00K | 258.00K | n/a | 8.00K |
| Receivables | n/a | n/a | n/a | n/a | 35.00K | 35.00K | n/a |
| Inventory | n/a | n/a | n/a | n/a | -11.97M | n/a | n/a |
| Other Current Assets | 9.92M | 21.33M | 11.21M | 14.01M | 6.43M | 485.00K | 223.00K |
| Total Current Assets | 347.60M | 438.42M | 240.75M | 373.27M | 231.10M | 2.41M | 655.00K |
| Property-Plant & Equipment | 74.00M | 73.08M | 56.34M | 34.81M | 18.02M | 1.47M | 677.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 75.81M | 75.08M | 57.38M | 35.36M | 30.25M | 1.57M | 735.00K |
| Total Assets | 423.41M | 513.50M | 298.13M | 408.63M | 261.35M | 3.98M | 1.39M |
| Account Payables | 1.33M | 2.51M | 5.58M | 7.92M | 3.09M | 164.00K | 225.00K |
| Deferred Revenue | 3.78M | 148.93M | n/a | n/a | n/a | 3.69M | 116.00K |
| Short-Term Debt | 5.83M | 11.63M | 6.64M | 5.33M | 4.97M | 8.32M | n/a |
| Other Current Liabilities | 31.54M | 27.80M | 15.56M | 3.98M | 822.00K | 3.59M | 507.00K |
| Total Current Liabilities | 42.48M | 44.69M | 27.78M | 17.24M | 8.88M | 8.89M | 976.00K |
| Long-Term Debt | 34.67M | 35.36M | 25.44M | 9.58M | 12.24M | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 60.92M | 40.79M |
| Total Long-Term Liabilities | 177.70M | 181.55M | 25.44M | 9.58M | 12.24M | 60.92M | 40.92M |
| Total Liabilities | 220.18M | 226.24M | 53.22M | 26.82M | 21.12M | 69.81M | 41.89M |
| Total Debt | 40.51M | 41.17M | 28.76M | 12.24M | 14.73M | 5.03M | n/a |
| Common Stock | 586.00K | 431.00K | 325.00K | 319.00K | 304.00K | 4.00K | 4.00K |
| Retained Earnings | -821.24M | -574.83M | -353.72M | -188.56M | -107.20M | -64.07M | -41.36M |
| Comprehensive Income | 151.00K | -701.00K | -66.00K | 26.00K | 43.00K | -667.00K | -389.00K |
| Shareholders Equity | 203.23M | -574.83M | -353.72M | -188.56M | -107.20M | -65.83M | -40.50M |
| Total Investments | 225.16M | 305.93M | 96.21M | 125.19M | 200.72M | 100.00K | 50.00K |